Granules India Reports Strong FY25 Despite Plant Challenges

Granules India, a pharmaceutical company, had a good financial year, with profits up significantly despite some production problems.

Although overall revenue slightly decreased, their profits went up by a lot.

This was helped by their focus on selling higher-profit items.

A factory in Gagillapur had some issues and needed repairs, which slowed down production.

Despite these challenges, the company's strong performance shows their ability to adapt and succeed.